411 related articles for article (PubMed ID: 26085914)
1. Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein.
Yu SJ; Kim YJ
World J Hepatol; 2015 Jun; 7(11):1553-61. PubMed ID: 26085914
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
3. Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90.
Lau WY; Sangro B; Chen PJ; Cheng SQ; Chow P; Lee RC; Leung T; Han KH; Poon RT
Oncology; 2013; 84(5):311-8. PubMed ID: 23615394
[TBL] [Abstract][Full Text] [Related]
4. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
[TBL] [Abstract][Full Text] [Related]
5. Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score and Bayesian analysis.
Martelletti C; Ricotti A; Gesualdo M; Carucci P; Gaia S; Rolle E; Burlone ME; Okolicsanyi S; Mattalia A; Pirisi M; Berchialla P; Tabone M
J Dig Dis; 2021 Aug; 22(8):496-502. PubMed ID: 34189839
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
7. Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides.
Khan AR; Wei X; Xu X
J Hepatocell Carcinoma; 2021; 8():1089-1115. PubMed ID: 34522691
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib
Hu HT; Luo JP; Cao GS; Li Z; Jiang M; Guo CY; Yuan H; Yao QJ; Geng X; Park JH; Cheng HT; Jiang L; Ma JL; Zhao Y; Li HL
Front Oncol; 2021; 11():806907. PubMed ID: 35004330
[TBL] [Abstract][Full Text] [Related]
9. Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis.
Hur MH; Cho Y; Kim DY; Lee JS; Kim GM; Kim HC; Sinn DH; Hyun D; Lee HA; Seo YS; Lee IJ; Park JW; Kim YJ
Clin Mol Hepatol; 2023 Jul; 29(3):763-778. PubMed ID: 37254488
[TBL] [Abstract][Full Text] [Related]
10. Chemoembolization Plus Radiotherapy Versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis.
Chu HH; Kim JH; Shim JH; Yoon SM; Kim PH; Alrashidi I
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365655
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
Zhang X; Wang K; Wang M; Yang G; Ye X; Wu M; Cheng S
Oncotarget; 2017 Apr; 8(17):29416-29427. PubMed ID: 28177886
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and safety of multimodality treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: patient-level network meta-analysis.
Leung JH; Wang SY; Leung HWC; Chan ALF
Front Oncol; 2024; 14():1344798. PubMed ID: 38434681
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus:a multicenter study.
Xiang X; Lau WY; Wu ZY; Zhao C; Ma YL; Xiang BD; Zhu JY; Zhong JH; Li LQ
Eur J Surg Oncol; 2019 Aug; 45(8):1460-1467. PubMed ID: 31005471
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
Zhang XP; Wang K; Li N; Zhong CQ; Wei XB; Cheng YQ; Gao YZ; Wang H; Cheng SQ
BMC Cancer; 2017 Dec; 17(1):902. PubMed ID: 29282010
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study.
Cao Y; Sun T; Guo X; Ouyang T; Kan X; Chen L; Liang B; Wang M; Zheng C
Front Oncol; 2021; 11():673378. PubMed ID: 34414104
[TBL] [Abstract][Full Text] [Related]
16. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
Fan W; Yuan G; Fan H; Li F; Wu Y; Zhao Y; Yao W; Wang Y; Xue M; Yang J; Li J
Clin Ther; 2019 Aug; 41(8):1463-1476. PubMed ID: 31303279
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review.
Han K; Kim JH; Ko GY; Gwon DI; Sung KB
World J Gastroenterol; 2016 Jan; 22(1):407-16. PubMed ID: 26755886
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in treatment strategies for hepatocellular carcinoma with portal vein cancer thrombus.
Tan ZB; Zhang J
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8119-8134. PubMed ID: 37750640
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis.
Zhang Y; Fan W; Wang Y; Lu L; Fu S; Yang J; Huang Y; Yao W; Li J
Oncologist; 2015 Dec; 20(12):1417-24. PubMed ID: 26446238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]